Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats

Abstract To establish the effect of dietary ω -3 PUFA on angiotensin II (ANG II)-mediated hypertension, male TGR (mRen-2)27 (Ren-2) rats (animals with high ANG II activity) were maintained on a diet either deficient or sufficient in ω -3 PUFA from conception. Half the animals on each diet were treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Prostaglandins, leukotrienes and essential fatty acids leukotrienes and essential fatty acids, 2008-01, Vol.78 (1), p.67-72
Hauptverfasser: Jayasooriya, A.P, Begg, D.P, Chen, N, Mathai, M.L, Sinclair, A.J, Wilkinson-Berka, J, Wark, J.D, Weisinger, H.S, Weisinger, R.S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 72
container_issue 1
container_start_page 67
container_title Prostaglandins, leukotrienes and essential fatty acids
container_volume 78
creator Jayasooriya, A.P
Begg, D.P
Chen, N
Mathai, M.L
Sinclair, A.J
Wilkinson-Berka, J
Wark, J.D
Weisinger, H.S
Weisinger, R.S
description Abstract To establish the effect of dietary ω -3 PUFA on angiotensin II (ANG II)-mediated hypertension, male TGR (mRen-2)27 (Ren-2) rats (animals with high ANG II activity) were maintained on a diet either deficient or sufficient in ω -3 PUFA from conception. Half the animals on each diet were treated with the angiotensin-converting enzyme inhibitor, perindopril, from birth. Ren-2 rats fed the ω -3 PUFA deficient diet were significantly more hypertensive than those fed the ω -3 PUFA sufficient diet. Perindopril reduced the blood pressure of both ω -3 PUFA-deficient and ω -3 PUFA-sufficient diet-fed Ren-2 rats. Body weight, body fat and plasma leptin were reduced by perindopril treatment but not affected by ω -3 PUFA supply. Given that the elevated blood pressure of the Ren-2 rat is mediated by ANG II, the data suggest that ω -3 PUFA may reduce hypertension via the renin–angiotensin system.
doi_str_mv 10.1016/j.plefa.2007.11.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70204285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952327807001779</els_id><sourcerecordid>70204285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-cd5e9603638456b14db6839c9bb4bac6d8ceaac289b096035f6442c1815bc4213</originalsourceid><addsrcrecordid>eNqFkk2L1TAUhoMoznX0FwjSjaKLXs9J-pEuFGTQURgYGMelhDQ91VzbtJOkQv-9qfei4MZVIDzve8JzwthThD0CVq8P-3mgXu85QL1H3APgPbbDUvCcSy7usx00Jc8Fr-UZexTCAQA4YvGQnaEEKUqoduzr9UjfdC6yeRrWxQUdF68jdVmvY1wzbWyXhWVOk0ZyUUc7ucxTtxgK2fd1Jh_Jhe3Suuz28ubleEMu5694naWa8Jg96PUQ6MnpPGdfPry_vfiYX11ffrp4d5WbouAxN11JTQWiErIoqxaLrq2kaEzTtkWrTdVJQ1obLpsWNq7sq5QzKLFsTcFRnLMXx97ZT3cLhahGGwwNg3Y0LUHVwKHgskygOILGTyF46tXs7aj9qhDUZlUd1G-rarOqEFWymlLPTvVLO1L3N3PSmIDnJ0AHo4fea2ds-MOlLg418sS9OXKUZPy05FUwlpyhznoyUXWT_c9D3v6TN4N1No38QSuFw7R4lzwrVIErUJ-3D7DtH-qUrutG_ALP9Kqm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70204285</pqid></control><display><type>article</type><title>Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jayasooriya, A.P ; Begg, D.P ; Chen, N ; Mathai, M.L ; Sinclair, A.J ; Wilkinson-Berka, J ; Wark, J.D ; Weisinger, H.S ; Weisinger, R.S</creator><creatorcontrib>Jayasooriya, A.P ; Begg, D.P ; Chen, N ; Mathai, M.L ; Sinclair, A.J ; Wilkinson-Berka, J ; Wark, J.D ; Weisinger, H.S ; Weisinger, R.S</creatorcontrib><description>Abstract To establish the effect of dietary ω -3 PUFA on angiotensin II (ANG II)-mediated hypertension, male TGR (mRen-2)27 (Ren-2) rats (animals with high ANG II activity) were maintained on a diet either deficient or sufficient in ω -3 PUFA from conception. Half the animals on each diet were treated with the angiotensin-converting enzyme inhibitor, perindopril, from birth. Ren-2 rats fed the ω -3 PUFA deficient diet were significantly more hypertensive than those fed the ω -3 PUFA sufficient diet. Perindopril reduced the blood pressure of both ω -3 PUFA-deficient and ω -3 PUFA-sufficient diet-fed Ren-2 rats. Body weight, body fat and plasma leptin were reduced by perindopril treatment but not affected by ω -3 PUFA supply. Given that the elevated blood pressure of the Ren-2 rat is mediated by ANG II, the data suggest that ω -3 PUFA may reduce hypertension via the renin–angiotensin system.</description><identifier>ISSN: 0952-3278</identifier><identifier>EISSN: 1532-2823</identifier><identifier>DOI: 10.1016/j.plefa.2007.11.001</identifier><identifier>PMID: 18083506</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Adipose Tissue - drug effects ; Advanced Basic Science ; Angiotensin II - blood ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Animals ; Antihypertensive Agents - pharmacology ; Antihypertensive Agents - therapeutic use ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Blood Pressure - drug effects ; Body Weight - drug effects ; Cardiology. Vascular system ; Eating - drug effects ; Endocrinology &amp; Metabolism ; Experimental diseases ; Fatty Acids, Omega-3 - administration &amp; dosage ; Fundamental and applied biological sciences. Psychology ; Hypertension - blood ; Hypertension - diet therapy ; Hypertension - drug therapy ; Hypertension - therapy ; Male ; Medical sciences ; Perindopril - therapeutic use ; Rats ; Renin - blood ; Vertebrates: endocrinology</subject><ispartof>Prostaglandins, leukotrienes and essential fatty acids, 2008-01, Vol.78 (1), p.67-72</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-cd5e9603638456b14db6839c9bb4bac6d8ceaac289b096035f6442c1815bc4213</citedby><cites>FETCH-LOGICAL-c442t-cd5e9603638456b14db6839c9bb4bac6d8ceaac289b096035f6442c1815bc4213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.plefa.2007.11.001$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20020712$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18083506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jayasooriya, A.P</creatorcontrib><creatorcontrib>Begg, D.P</creatorcontrib><creatorcontrib>Chen, N</creatorcontrib><creatorcontrib>Mathai, M.L</creatorcontrib><creatorcontrib>Sinclair, A.J</creatorcontrib><creatorcontrib>Wilkinson-Berka, J</creatorcontrib><creatorcontrib>Wark, J.D</creatorcontrib><creatorcontrib>Weisinger, H.S</creatorcontrib><creatorcontrib>Weisinger, R.S</creatorcontrib><title>Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats</title><title>Prostaglandins, leukotrienes and essential fatty acids</title><addtitle>Prostaglandins Leukot Essent Fatty Acids</addtitle><description>Abstract To establish the effect of dietary ω -3 PUFA on angiotensin II (ANG II)-mediated hypertension, male TGR (mRen-2)27 (Ren-2) rats (animals with high ANG II activity) were maintained on a diet either deficient or sufficient in ω -3 PUFA from conception. Half the animals on each diet were treated with the angiotensin-converting enzyme inhibitor, perindopril, from birth. Ren-2 rats fed the ω -3 PUFA deficient diet were significantly more hypertensive than those fed the ω -3 PUFA sufficient diet. Perindopril reduced the blood pressure of both ω -3 PUFA-deficient and ω -3 PUFA-sufficient diet-fed Ren-2 rats. Body weight, body fat and plasma leptin were reduced by perindopril treatment but not affected by ω -3 PUFA supply. Given that the elevated blood pressure of the Ren-2 rat is mediated by ANG II, the data suggest that ω -3 PUFA may reduce hypertension via the renin–angiotensin system.</description><subject>Adipose Tissue - drug effects</subject><subject>Advanced Basic Science</subject><subject>Angiotensin II - blood</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Animals</subject><subject>Antihypertensive Agents - pharmacology</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Pressure - drug effects</subject><subject>Body Weight - drug effects</subject><subject>Cardiology. Vascular system</subject><subject>Eating - drug effects</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Experimental diseases</subject><subject>Fatty Acids, Omega-3 - administration &amp; dosage</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hypertension - blood</subject><subject>Hypertension - diet therapy</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Perindopril - therapeutic use</subject><subject>Rats</subject><subject>Renin - blood</subject><subject>Vertebrates: endocrinology</subject><issn>0952-3278</issn><issn>1532-2823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk2L1TAUhoMoznX0FwjSjaKLXs9J-pEuFGTQURgYGMelhDQ91VzbtJOkQv-9qfei4MZVIDzve8JzwthThD0CVq8P-3mgXu85QL1H3APgPbbDUvCcSy7usx00Jc8Fr-UZexTCAQA4YvGQnaEEKUqoduzr9UjfdC6yeRrWxQUdF68jdVmvY1wzbWyXhWVOk0ZyUUc7ucxTtxgK2fd1Jh_Jhe3Suuz28ubleEMu5694naWa8Jg96PUQ6MnpPGdfPry_vfiYX11ffrp4d5WbouAxN11JTQWiErIoqxaLrq2kaEzTtkWrTdVJQ1obLpsWNq7sq5QzKLFsTcFRnLMXx97ZT3cLhahGGwwNg3Y0LUHVwKHgskygOILGTyF46tXs7aj9qhDUZlUd1G-rarOqEFWymlLPTvVLO1L3N3PSmIDnJ0AHo4fea2ds-MOlLg418sS9OXKUZPy05FUwlpyhznoyUXWT_c9D3v6TN4N1No38QSuFw7R4lzwrVIErUJ-3D7DtH-qUrutG_ALP9Kqm</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Jayasooriya, A.P</creator><creator>Begg, D.P</creator><creator>Chen, N</creator><creator>Mathai, M.L</creator><creator>Sinclair, A.J</creator><creator>Wilkinson-Berka, J</creator><creator>Wark, J.D</creator><creator>Weisinger, H.S</creator><creator>Weisinger, R.S</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats</title><author>Jayasooriya, A.P ; Begg, D.P ; Chen, N ; Mathai, M.L ; Sinclair, A.J ; Wilkinson-Berka, J ; Wark, J.D ; Weisinger, H.S ; Weisinger, R.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-cd5e9603638456b14db6839c9bb4bac6d8ceaac289b096035f6442c1815bc4213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adipose Tissue - drug effects</topic><topic>Advanced Basic Science</topic><topic>Angiotensin II - blood</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Animals</topic><topic>Antihypertensive Agents - pharmacology</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Pressure - drug effects</topic><topic>Body Weight - drug effects</topic><topic>Cardiology. Vascular system</topic><topic>Eating - drug effects</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Experimental diseases</topic><topic>Fatty Acids, Omega-3 - administration &amp; dosage</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hypertension - blood</topic><topic>Hypertension - diet therapy</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Perindopril - therapeutic use</topic><topic>Rats</topic><topic>Renin - blood</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jayasooriya, A.P</creatorcontrib><creatorcontrib>Begg, D.P</creatorcontrib><creatorcontrib>Chen, N</creatorcontrib><creatorcontrib>Mathai, M.L</creatorcontrib><creatorcontrib>Sinclair, A.J</creatorcontrib><creatorcontrib>Wilkinson-Berka, J</creatorcontrib><creatorcontrib>Wark, J.D</creatorcontrib><creatorcontrib>Weisinger, H.S</creatorcontrib><creatorcontrib>Weisinger, R.S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Prostaglandins, leukotrienes and essential fatty acids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jayasooriya, A.P</au><au>Begg, D.P</au><au>Chen, N</au><au>Mathai, M.L</au><au>Sinclair, A.J</au><au>Wilkinson-Berka, J</au><au>Wark, J.D</au><au>Weisinger, H.S</au><au>Weisinger, R.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats</atitle><jtitle>Prostaglandins, leukotrienes and essential fatty acids</jtitle><addtitle>Prostaglandins Leukot Essent Fatty Acids</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>78</volume><issue>1</issue><spage>67</spage><epage>72</epage><pages>67-72</pages><issn>0952-3278</issn><eissn>1532-2823</eissn><abstract>Abstract To establish the effect of dietary ω -3 PUFA on angiotensin II (ANG II)-mediated hypertension, male TGR (mRen-2)27 (Ren-2) rats (animals with high ANG II activity) were maintained on a diet either deficient or sufficient in ω -3 PUFA from conception. Half the animals on each diet were treated with the angiotensin-converting enzyme inhibitor, perindopril, from birth. Ren-2 rats fed the ω -3 PUFA deficient diet were significantly more hypertensive than those fed the ω -3 PUFA sufficient diet. Perindopril reduced the blood pressure of both ω -3 PUFA-deficient and ω -3 PUFA-sufficient diet-fed Ren-2 rats. Body weight, body fat and plasma leptin were reduced by perindopril treatment but not affected by ω -3 PUFA supply. Given that the elevated blood pressure of the Ren-2 rat is mediated by ANG II, the data suggest that ω -3 PUFA may reduce hypertension via the renin–angiotensin system.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>18083506</pmid><doi>10.1016/j.plefa.2007.11.001</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0952-3278
ispartof Prostaglandins, leukotrienes and essential fatty acids, 2008-01, Vol.78 (1), p.67-72
issn 0952-3278
1532-2823
language eng
recordid cdi_proquest_miscellaneous_70204285
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adipose Tissue - drug effects
Advanced Basic Science
Angiotensin II - blood
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Animals
Antihypertensive Agents - pharmacology
Antihypertensive Agents - therapeutic use
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Blood Pressure - drug effects
Body Weight - drug effects
Cardiology. Vascular system
Eating - drug effects
Endocrinology & Metabolism
Experimental diseases
Fatty Acids, Omega-3 - administration & dosage
Fundamental and applied biological sciences. Psychology
Hypertension - blood
Hypertension - diet therapy
Hypertension - drug therapy
Hypertension - therapy
Male
Medical sciences
Perindopril - therapeutic use
Rats
Renin - blood
Vertebrates: endocrinology
title Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T01%3A11%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Omega-3%20polyunsaturated%20fatty%20acid%20supplementation%20reduces%20hypertension%20in%20TGR(mRen-2)27%20rats&rft.jtitle=Prostaglandins,%20leukotrienes%20and%20essential%20fatty%20acids&rft.au=Jayasooriya,%20A.P&rft.date=2008-01-01&rft.volume=78&rft.issue=1&rft.spage=67&rft.epage=72&rft.pages=67-72&rft.issn=0952-3278&rft.eissn=1532-2823&rft_id=info:doi/10.1016/j.plefa.2007.11.001&rft_dat=%3Cproquest_cross%3E70204285%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70204285&rft_id=info:pmid/18083506&rft_els_id=S0952327807001779&rfr_iscdi=true